The ImmunoSABR project is consortium of 15 partners which has been created from leading Institutes within the EU . Working together their aim is to open up a new paradigm in treating metastatic cancer by obtaining clinical proof of concept for a novel bi-modal curative treatment strategy.
University College London
University College London Cancer Institute and the University College Hospital form a leading UK Comprehensive Cancer Centre, combining basic cancer [...]
Universitair Ziekenhuis Gent
UZ Gent is one of the largest and most specialized hospitals in Flanders, delivering a full range of highly specialized, [...]
Universitaets Klinikum Tuebingen
We are an academic tertiary care center treating 2500 new cancer patients per year (>45000 fractions). Our clinical and scientific [...]
The Università Cattolica del Sacro Cuore is the most comprehensive and complete legally recognized university in Italy: it includes five [...]
The Cliniques Universitaires Saint-Luc
The Cliniques Universitaires Saint-Luc (CUSL - UCL) is one of the main academic hospitals of Brussels, and is currently treating [...]
Technische Universität Dresden
OncoRay is an interdisciplinary research center established in 2005 and financed by the Technische Universität Dresden, the University Hospital Dresden [...]
Radboud university medical center is a leading academic center for patient care, education and research, with the mission ‘to have [...]
Philogen (http://www.philogen.com/) was founded in 1996 with the mission to develop new bio- pharmaceuticals for the treatment of angiogenesis-related disorders, [...]
The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital (NKI-AVL) is an integrated comprehensive cancer centre, combining a hospital and [...]
Maastricht UMC +
The University of Maastricht (UM) and the University Medical Center Maastricht (azM) work together under the umbrella organisation Maastricht UMC+, [...]
The Leuven Lung Cancer Group (LLCG) is a world- wide recognised high-quality clinical and experimental hub in which innovative diagnosis [...]
Health Innovation Ventures B.V.
Health Innovation Ventures B.V. aims to revolutionise healthcare through several approaches. Specifically, two departments of Health Innovation V entures will [...]
STAY INFORMED ?
If you want to stay informed about ImmunoSABR project, please subscribe to our newsletter.
The D-Lab / Precision Medicine
P.O. Box 616,
6200 MD Maastricht, The Netherlands
This project has received funding from the European Union’s. Horizon 2020 research and innovation programme under grant agreement No 733008